NovaBay Pharmaceuticals reported a second quarter net loss of $2.5 million, or $0.14 per share, compared with a net loss of $1.6 million, or $0.09 per share, in the same period of 2018, according to a press release.
Net sales in the second quarter totaled $1.8 million compared with $2.8 million a year ago; $1.6 million came from sales of Avenova and $0.2 million from a stocking order.
Sales and marketing expenses were $1.5 million in second quarter 2019 compared with $3 million during the same period in 2018. Research (Read more...)
Uncategorized